Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies.
about
Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1Additive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodiesDistinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodiesStructural Analysis of Human and Macaque mAbs 2909 and 2.5B: Implications for the Configuration of the Quaternary Neutralizing Epitope of HIV-1 gp120Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 Env-mediated fusion depends on sequence and accessibility of the gp41 loop regionTargeted killing of virally infected cells by radiolabeled antibodies to viral proteinsLongitudinal study of primary HIV-1 isolates in drug-naïve individuals reveals the emergence of variants sensitive to anti-HIV-1 monoclonal antibodiesNeutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from IndiaHIV-1 fusion is blocked through binding of GB Virus C E2-derived peptides to the HIV-1 gp41 disulfide loop [corrected]A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusionThe ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptidePre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradicationSurvivors Remorse: antibody-mediated protection against HIV-1.Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins.Oligomer-specific conformations of the human immunodeficiency virus (HIV-1) gp41 envelope glycoprotein ectodomain recognized by human monoclonal antibodiesAntibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics.Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.Identification of a gp41 core-binding molecule with homologous sequence of human TNNI3K-like protein as a novel human immunodeficiency virus type 1 entry inhibitor.Peptides of a novel Mycobacterium tuberculosis-specific cell wall protein for immunodiagnosis of tuberculosis.Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes.A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex.Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1.Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in MacaquesAnti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activityFunctional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.Conserved, N-linked carbohydrates of human immunodeficiency virus type 1 gp41 are largely dispensable for viral replication.Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses.Mutation-directed chemical cross-linking of human immunodeficiency virus type 1 gp41 oligomers.Effect of nonprotective vaccination on antibody response to subsequent human immunodeficiency virus infection.Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry.GPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike.Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived from the same infected subject
P2860
Q24533287-1A058C9E-CECC-48E9-8C6D-3CAE98F431C1Q24541449-A537619D-9C4A-4B3C-A667-B7ECAAF3C5DBQ27469855-FEC04434-9237-404F-A133-09B755CBFA25Q27485578-B8518A7E-0060-4C21-BB2D-F0C1F2001AF1Q27665884-A8F872EC-A7CF-4F24-89A3-233DF6736AA7Q27667819-880B5D31-9087-485F-8074-6211815320DAQ28343901-8EDC001F-98D9-4178-A267-0B734FA8565BQ28469068-75E00809-FDD3-45B6-BDFD-242FE5D8F934Q28477253-BB647082-C77B-49AD-B247-6A76E7BFF449Q28483205-AE42944A-AEAB-49C6-BABA-B651D9788ABBQ28485218-516819A3-78BC-49A7-B532-27F0EEF0B49BQ28646828-4839E408-071F-4B2A-912C-D3FC7A166E4BQ28646857-99393EBC-58D3-4D73-B915-25AD11396BD7Q28731318-BC3A9806-E831-4A96-84BB-8C96BD195C25Q30238730-E2044132-C925-4EF1-ABA7-94452E6A1DB4Q30358769-2B6A1D9C-7EFF-4A5C-89B0-9EA10578857DQ30436401-9FD21BA7-4708-417B-BE3A-AD19AB919C50Q30843874-98813C70-E320-4A1E-9ECA-ABA3731C5B5BQ31016954-5CC272CB-FFEE-4536-BD09-1B1AE56FB863Q33205911-2A9C035D-4516-44BC-A867-CB93FDCEAA3EQ33622229-428447BD-5D90-4195-AB10-7C6486CCF5F5Q33757313-997A326C-1587-4A72-B9A1-67AC122944DDQ33787329-E66D8565-0973-48F8-B2F7-F3B9F9329F8FQ33803590-192D80BC-341B-456B-B931-5D325EA97E7AQ33807129-E2C6DFB2-A243-4348-911E-880CEB88DA90Q33809112-622D224E-1177-471C-9D70-3AF4E2FCD3ABQ33815502-60615B91-C6AE-4035-874E-8C36DD14F999Q33819493-BB2002E1-EA90-4F50-89C6-B7581F5C5A58Q33826951-59B0276B-6CDA-487F-910D-89340489F20FQ33843696-93CCA4C2-5840-4C5F-8E06-7187AC237908Q33849755-BB86A48A-699E-444A-B950-D2F122425189Q33898692-EB106D81-2911-4E25-8D87-0E111DB13942Q33965511-6B031120-2694-4D65-8DDE-AD982EDC487BQ34023249-DE89E060-0BFF-4905-8D13-A191808019F5Q34070049-F57670E3-55DD-43FF-B1A5-670BBA27072DQ34119444-F18B4431-08F3-46C7-B875-26D9055708DFQ34145199-2A6B0DC0-FA1E-4FC0-9E8E-735C164EF2F1Q34146728-61303F1F-4D72-48BF-90F4-2EE80DBEEC30Q34221625-DCC82BFB-2957-419E-A54D-85223ACC545AQ34326222-B38E17B3-A356-471E-86CF-5ACC71D402B1
P2860
Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Epitope mapping of two immunod ...... n human monoclonal antibodies.
@en
type
label
Epitope mapping of two immunod ...... n human monoclonal antibodies.
@en
prefLabel
Epitope mapping of two immunod ...... n human monoclonal antibodies.
@en
P2093
P2860
P1433
P1476
Epitope mapping of two immunod ...... n human monoclonal antibodies.
@en
P2093
P2860
P304
P407
P577
1991-09-01T00:00:00Z